Meloxicam Teva (Meloxicam)

Meloxicam works by reversibly inhibiting the cyclo‑oxygenase enzymes COX‑1 and COX‑2, with a greater preference for COX‑2. This inhibition blocks the conversion of arachidonic acid into prostaglandins, which are key mediators of inflammation, pain and fever. Reduced prostaglandin levels lead to decreased swelling, pain perception and fever response.

The specific dose of meloxicam is determined by the prescribing healthcare professional based on the patient’s condition, severity, age, renal and hepatic function, and other individual factors. Dosage regimens are not standardized in public information and should always follow the prescriber’s written instructions.

Safety data for meloxicam during pregnancy and lactation are limited, and the product is classified with an unknown pregnancy category. It should generally be avoided unless the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Meloxicam Teva. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details and any necessary import documentation.

Meloxicam offers a longer half‑life than many traditional NSAIDs such as ibuprofen, allowing once‑daily dosing for many patients. Its preferential COX‑2 inhibition may reduce gastrointestinal side effects compared with non‑selective NSAIDs, but it still carries cardiovascular and renal risks similar to other agents in the class. Choice of NSAID should be individualized based on efficacy, safety profile and patient comorbidities.

Meloxicam Teva should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Do not store in humid areas such as bathrooms, and keep the product out of reach of children.

Meloxicam Teva is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may lessen stomach upset. The tablet should be swallowed whole and not crushed or chewed.

Serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, severe skin reactions like Stevens‑Johnson syndrome, liver injury, and acute kidney failure. Patients should seek immediate medical attention if they experience symptoms such as black stools, chest pain, sudden swelling, rash, jaundice, or a rapid decline in urine output.

Meloxicam should be avoided in individuals with known hypersensitivity to meloxicam or other oxicam NSAIDs, active gastrointestinal ulceration or bleeding, severe heart failure, uncontrolled hypertension, and in patients with severe renal or hepatic impairment. It is also contraindicated in those who have had a recent coronary artery bypass graft surgery.